Get the Stockscreener App
9.31
8.76%
0.75
After Hours:
9.12
-0.19
-2.04%
Metavia Inc stock is traded at $9.31, with a volume of 80,565.
It is up +8.76% in the last 24 hours and up +19.81% over the past month.
MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases. It has two programs focused on the treatment of metabolic dysfunction-associated steatohepatitis (MASH) and obesity. DA-1241 is a novel G-Protein-Coupled Receptor 119 (GPR119) agonist with development optionality as a standalone and/or combination therapy for both MASH and Type 2 Diabetes Mellitus (T2DM). DA-1726 is a novel oxyntomodulin (OXM) analogue functioning as a GLP-1 receptor (GLP1R) and glucagon receptor (GCGR) dual agonist for the treatment of obesity that is designed to be administered once weekly subcutaneously.
See More
Previous Close:
$8.56
Open:
$8.6
24h Volume:
80,565
Relative Volume:
0.28
Market Cap:
$21.50M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+13.79%
1M Performance:
+19.81%
6M Performance:
+12.85%
1Y Performance:
-63.28%
1-Day Range:
$8.49
$9.68
1-Week Range:
$8.01
$13.42
52-Week Range:
$6.05
$30.25
Metavia Inc Stock (MTVA) Company Profile
Name
Metavia Inc
Sector
Industry
Phone
(857) 702-9600
Address
545 CONCORD AVENUE, CAMBRIDGE
Compare MTVA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MTVA
Metavia Inc
|
9.31 | 19.77M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Metavia Inc Stock (MTVA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-04-25 | Resumed | H.C. Wainwright | Buy |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
Metavia Inc Stock (MTVA) Latest News
MTVA: New Date for Vanoglipel (DA-1241) Presented at AASLD… - Zacks Small Cap Research
Fundamentals Check: Can MetaVia Inc stock rebound after recent weaknessWeekly Trade Summary & Stock Timing and Entry Methods - moha.gov.vn
The time has not yet come to remove your chips from the table: MetaVia Inc (MTVA) - setenews.com
MetaVia (MTVA) price target increased by 1,000.00% to 159.88 - MSN
Exit Recap: What risks investors should watch in MetaVia Inc. stockJuly 2025 Action & Growth Oriented Trading Recommendations - BỘ NỘI VỤ
MetaVia Inc. (MTVA) Stock Jumps After Reverse Split: What the New Price, Trial Data and 2026 Forecast Mean for Investors - ts2.tech
Will MetaVia Inc. stock continue dividend increasesJuly 2025 Reactions & Technical Pattern Alert System - Newser
MetaVia Inc. trading halted, news pending - MSN
MetaVia announces 1-for-11 reverse stock split; shares slip over 15% - MSN
METAVIAPAR: Target Price Consensus and Analysts Recommendations | MTVA | US64132R4048 - marketscreener.com
IMG, MTVA, USREF, TGL: These four stocks trade ex-reverse split on Friday - MSN
MetaVia Inc. (MTVA) -6.08% in After-hours: Shares Down Following Split Announcement - Stocks Telegraph
IMG, MTVA, USREF, TGL: These Four Stocks Trade Ex-Reverse Split On Friday - Stocktwits
What insider trading reveals about MetaVia Inc. stockExit Point & Risk Controlled Swing Alerts - Newser
MetaVia To Carry Out 1-for-11 Reverse Stock Split On December 5th, 2025 - 富途牛牛
MetaVia implements 1-for-11 reverse stock split - MSN
MetaVia to Implement 1-for-11 Reverse Stock Split - marketscreener.com
MetaVia Announces Reverse Stock Split to Meet Nasdaq Rules - TipRanks
MetaVia announces 1-for-11 reverse stock split effective December 4 - Investing.com Canada
Metavia Inc. announces 1-for-11 reverse stock split - marketscreener.com
Metavia Inc. Announces 1-For-11 Reverse Stock Split - TradingView — Track All Markets
MetaVia Inc. Announces 1-for-11 Reverse Stock Split - PR Newswire
Dow Update: What margin trends mean for MetaVia Inc. stockGap Up & Long-Term Growth Plans - moha.gov.vn
Ready to Jump After Recent Trade: MetaVia Inc (MTVA) - Setenews
MetaVia Seeks Extension to Regain Nasdaq Compliance - MSN
MetaVia granted Nasdaq time to fix sub-$1.00 share price - Stock Titan
MetaVia Inc. (MTVA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Will MetaVia Inc. stock maintain momentum in 2025Weekly Trade Analysis & Safe Entry Point Identification - newser.com
How MetaVia Inc. stock compares to growth peers2025 Technical Overview & Reliable Breakout Forecasts - newser.com
How MetaVia Inc. stock benefits from tech adoptionMarket Rally & Consistent Growth Equity Picks - newser.com
How MetaVia Inc. stock reacts to bond yields2025 Support & Resistance & Growth Focused Investment Plans - newser.com
How to manage a losing position in MetaVia Inc.Weekly Market Report & Daily Chart Pattern Signal Reports - newser.com
Reversal indicators forming on MetaVia Inc. stockJuly 2025 Levels & Risk Managed Investment Signals - newser.com
Real time breakdown of MetaVia Inc. stock performanceJuly 2025 Market Mood & Fast Exit and Entry Strategy Plans - newser.com
Metavia Inc Stock (MTVA) Financials Data
There is no financial data for Metavia Inc (MTVA). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Metavia Inc Stock (MTVA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| DONG-A ST CO., LTD | 10% Owner |
May 08 '25 |
Buy |
0.71 |
4,647,887 |
3,300,000 |
9,995,679 |
1.08%
0.91%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):